Fredun Pharmaceuticals fundamental analysis

FREDUN

1688.4

27.80 (-1.62%)
Last updated on 2 Apr, 2026 | 13:52 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Fredun Pharmaceuticals Fundamentals

P/E Ratio

28.74

P/B Ratio

3.59

Div. Yield

0.04

Sector P/E

59.77

Sector P/B

3.14

Sec. Div. Yield

0.6

Fredun Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 28.74, compared to the sector average of 59.77. Its P/B Ratio stands at 3.59, while the sector’s is 3.14. In terms of returns, the stock offers a Dividend Yield of 0.04%, which is than the sector’s 0.6%.

Fredun Pharmaceuticals Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Good

On its scorecard, Fredun Pharmaceuticals reflects: Price – Attractive, Growth – Good, Quality – Poor, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost